Research
Read how they describe their research on their Queen's University profile.
Latest funding
- $198,942
Development of therapeutics for prevention and treatment of pre-eclampsia: One of the leading causes of preterm birth in Canada.
CIHR · 2016 · Co-investigator
- $120,000
Chemically-induced Ventricular Septation Defects; Mechanisms and Long-term Health Consequences
ONTARIO · 2012 · Principal investigator
- $120,000
Chemically-induced Ventricular Septation Defects; Mechanisms and Long-term Health Consequences
CFI · 2011 · Principal investigator
No publications available.
Development of therapeutics for prevention and treatment of pre-eclampsia: One of the leading causes of preterm birth in Canada.
Principal investigators: Smith, Graeme N
Keywords: Epigenetics; Fetus And Growth Restriction; Heart Disease; Pregnancy And Pre-Eclampsia; Women
Chemically-induced Ventricular Septation Defects; Mechanisms and Long-term Health Consequences
Principal investigators: Ozolins, Terence
Chemically-induced Ventricular Septation Defects; Mechanisms and Long-term Health Consequences
Principal investigators: Ozolins, Terence
Keywords: whole embryo culture, ventricular septation defect, teratogenesis, epigenetics, heart defect
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.